HLA-B27 is the Gene Most Strongly Correlated with Both Axial Spondyloarthritis and Uveitis
HLA-B27 is definitively the gene with the strongest correlation to both axial spondyloarthritis (axSpA) and acute anterior uveitis (AAU), representing the dominant shared genetic risk factor between these two conditions. 1
Strength of HLA-B27 Association
In Axial Spondyloarthritis
- HLA-B27 is positive in 74% to 89% of patients with axSpA, demonstrating an exceptionally strong association 1
- Among HLA-B27-positive first-degree relatives, approximately 25% developed axSpA over 35 years of follow-up, compared to only 3% of HLA-B27-negative relatives 1
- The association is so robust that HLA-B27 positivity increases the likelihood of peripheral spondyloarthritis and is a key diagnostic consideration 1
In Uveitis
- Acute anterior uveitis occurred significantly more frequently in first-degree relatives who later developed axSpA (odds ratio 4.7; 95% CI 2.2-10.5), with HLA-B27 being the underlying genetic link 1
- HLA-B27-associated AAU shares the same genetic architecture as axSpA, with HLA-B27 showing association P<10^-300 in comparative studies 2
- Uveitis serves as a potential predictor of axSpA development, mediated through the shared HLA-B27 genetic pathway 1
Additional Genetic Factors (Secondary to HLA-B27)
While HLA-B27 dominates, other genes show associations but with substantially weaker effects:
ERAP1
- Shows association with both conditions, but this association is restricted to HLA-B27-positive disease 2, 3
- Demonstrates differential impact on AAU risk compared to AS alone, suggesting gene-environment interaction with HLA-B27 2
HLA-A*02:01
- Shows secondary association with AAU (P=6×10^-8), but far weaker than HLA-B27 2
Other MHC Region Genes
- PSORS1C3 (P=4.7×10^-5) and TAP2 (P=1.1×10^-5) show secondary independent associations within the major histocompatibility complex 2
Clinical Implications
Diagnostic Considerations
- Spondyloarthritis should not be ruled out based solely on negative HLA-B27 testing, as the disease can occur in HLA-B27-negative individuals, though less commonly 1
- HLA-B27 positivity combined with clinical features (inflammatory back pain, uveitis, family history) substantially increases diagnostic probability 1
Prognostic Reassurance
- HLA-B27 carriage alone does not adversely impact survival in individuals without axSpA, including no increased cardiovascular mortality 1
- No significant mortality differences exist between HLA-B27-positive and HLA-B27-negative patients within either radiographic or non-radiographic axSpA groups 1
Mechanistic Understanding
The pathogenic mechanism involves:
- Expanded CD8+ T cell subsets bearing unique T cell receptor motifs (TRAV21/TRBV9) in HLA-B27-positive patients with axSpA or AAU 4
- These T cells can bind both self-derived and bacterial peptides, supporting the "arthritogenic peptide" hypothesis 4
- Evidence suggests early antigen exposure and differentiation of pathogenic CD8+ T cells may occur in enteric organs, with mucosal signatures found in ocular and synovial T cells 5